JP Morgan’s chief global market strategist, Marko Kolanovic, wrote in a report to clients: “We believe that 2022 will be a year of full global recovery, and the global epidemic will end and return to the normal conditions before the outbreak of the new crown. Extensive herd immunity and new therapies spawned by human wisdom will contribute to this reality, and the new therapies are expected to be widely used in 2022. "This optimism is worth encouraging, but it is hard to say how the reality develops. However, the epidemic is actually a political issue and does not entirely depend on medical treatment.
As long as the epidemic continues, a full cut cannot be done, and the new cold war will continue to deepen at all levels other than the military. Now the virus is constantly mutating and fluctuates every 2-3 months. The number of people infected worldwide is increasing. It is almost impossible to fully recover in just one year. Omicorn is very contagious but the symptoms are mild, but this cannot be used as evidence of the remission of the virus, and it is likely that the next outbreak will be more intense.
The U.S. rescues the economy through unlimited currency issuance, and it is the general trend that the hyperinflation market will close next year. The soaring U.S. stocks driven by funds will inevitably adjust and fall sharply, triggering global market volatility, coupled with repeated epidemics, and the economic outlook is not optimistic. As long as the new cold war continues, the global economy will not be able to fully recover, but will continue to fluctuate sharply up and down.
If the epidemic really ends, Europe
and the United States will concentrate all their energy on their competitors,
and such a new wave of global shocks will begin again. In the struggle against
the epidemic after the trade war, the next unlimited war is unpredictable.
Global confrontation under the new cold war is inevitable, and the world
economy will continue to rush to regular shocks amidst large fluctuations.
沒有留言:
張貼留言